Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071604
Status:
UNKNOWN
Last Update Posted:
2013-05-06
First Post:
2003-10-29
Brief Title:
Medication Adherence in Older People With Psychosis
Sponsor:
Veterans Medical Research Foundation
Organization:
Veterans Medical Research Foundation
Study Overview
Official Title:
Medication Adherence in Older Psychotic People
Status:
UNKNOWN
Status Verified Date:
2008-04
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will determine whether Medication Adherence Therapy MAT can improve medication adherence and lower the risk of rehospitalization in older patients with psychosis
Detailed Description:
Psychoses are among the most common and serious psychiatric disorders Currently the most effective treatment for psychoses involves the use of antipsychotic or neuroleptic medications Unfortunately pharmacologic regimens often do not achieve their goals because of poor medication adherence Nonadherence to antipsychotic treatment is a considerable public health problem that leads to myriad clinical and economic burdens including psychotic relapse increased clinic and emergency room visits and rehospitalization
Participants in this study are randomly assigned to receive either MAT or supportive treatment for 12 weeks MAT is given in 15 sessions and consists of motivational interviewing education and social skills and behavior modification Individual MAT sessions are held in Weeks 1 and 12 small group sessions take place in Weeks 2 through 11 Three monthly booster group sessions begin in Week 16 Participants are assessed at baseline and at 3 6 and 12 months Medication adherence psychopathology quality of life medication side effects health beliefs and functioning are assessed
Participants in this study are randomly assigned to receive either MAT or supportive treatment for 12 weeks MAT is given in 15 sessions and consists of motivational interviewing education and social skills and behavior modification Individual MAT sessions are held in Weeks 1 and 12 small group sessions take place in Weeks 2 through 11 Three monthly booster group sessions begin in Week 16 Participants are assessed at baseline and at 3 6 and 12 months Medication adherence psychopathology quality of life medication side effects health beliefs and functioning are assessed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DATR A4-GPS | US NIH GrantContract | None | httpsreporternihgovquickSearchR01MH062849 |
| R01MH062849 | NIH | None | None |